Neonc Technologies Holdings NTHI
NASDAQ NTHI
$3.40 +0.11 (+3.18%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neonc Technologies Holdings (NTHI) EBITDA Margin (2024)

Updated

Neonc Technologies Holdings (NTHI) reported EBITDA Margin of -145546.35% for FY2025, down 137237.22 percentage points from -8309.13% in FY2024.

Analysis

Neonc Technologies Holdings (NTHI) EBITDA Margin (2024) Analysis & Trends

  • According to Business Quant data, EBITDA Margin came in at -8309.13% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 Neonc Technologies Holdings 85.58 Mn 85.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -10,233.28%
API Access

Neonc Technologies Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NTHI&period=max&api_key=YOUR_API_KEY